Photoactivable Polymers Embedded with Cadmium-Free Quantum Dots and Crystal Violet: Efficient Bactericidal Activity against Clinical Strains of Antibiotic-Resistant Bacteria
Source abstract
Abstract
The rising incidence of antibiotic-resistant infections from contaminated surfaces in hospitals or implanted medical devices has led to increasing interest in new antibacterial surfaces. Photoactivatable surfaces that can generate cytotoxic reactive oxygen species under exposure to ambient light is a promising approach to inactivation of surface-borne microorganisms. There is growing interest in the use of quantum dots (QDs) as light-harvesting agents for photobactericidal applications, but the cadmium in commonly used QDs will restrict clinical application. Herein, the photobactericidal activity of novel polyurethane substrates containing cadmium-free QDs was tested against clinical multidrug-resistant Gram-positive and Gram-negative bacterial strains: methicillin-resistant Staphylococcus aureus (MRSA) and a carbapenemase-producing strain of Escherichia coli ( E. coli). To enhance the capacity for reactive oxygen species generation, QDs were incorporated into the polymer with a photosensitizing dye, crystal violet. Close proximity between the QD and dye enables electron and energy transfer processes leading to generation of cytotoxic singlet oxygen and superoxide radicals. A QD solution in cyclohexane was premixed with a solution of CV in the more polar solvent, dichloromethane, to promote the formation of QD-CV nanocomposite complexes via CV adsorption. This solution was then used to embed the QDs and crystal violet into medical grade polyurethane via swell-encapsulation. The combination of QD and CV elicited significant synergistic antibacterial activity under visible light against MRSA within 1 h (99.98% reduction) and E. coli within 4 h (99.96% reduction). Photoluminescence lifetime and singlet oxygen phosphorescence measurements demonstrated that interaction between the QDs and the crystal violet occurs within the polymer and leads to enhanced generation of reactive oxygen species. Strong inhibition of kill was observed using the superoxide scavenger, superoxide dismutase. The efficacy of these QD-CV polymer substrates, that can harvest light across the visible spectrum, against multidrug-resistant bacteria demonstrates the feasibility of this approach.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Photocatalysis Techniques · Quantum Dots Synthesis And Properties
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
UCL Division of Surgery and Interventional Science, University College London, Charles Bell House, 43-45 Foley Street, London W1W 7TS, U.K.
Materials Chemistry Research Centre, Department of Chemistry, University College London, 20 Gordon Street, London WC1H 0AJ, U.K.
Department of Microbial Diseases, UCL Eastman Dental Institute, University College London, 256 Gray’s Inn Road, London WC1X 8LD, U.K.
Nanoco Technologies Ltd, 46 Grafton Street, Manchester M13 9NT, U.K.
Funding
Medical Research Council
References (69)
Show source-provided references
1. Organisation for Economic Co-operation and Development (OECD). · 2016
2. 10.1177/00333549071220020510.1177/003335490712200205 ↗
3. 10.4103/2279-042X.17655910.4103/2279-042X.176559 ↗
4. Report on the Burden of Endemic Health Care-Associated Infection Worldwide; World Health Organization (WHO), 2011.
5. Collins A. · 2008
6. 10.1111/j.1574-695x.1997.tb01074.x10.1111/j.1574-695x.1997.tb01074.x ↗
7. 10.1016/j.ibiod.2003.11.00610.1016/j.ibiod.2003.11.006 ↗
8. 10.1128/aem.71.11.6918-6925.200510.1128/aem.71.11.6918-6925.2005 ↗
9. 10.1016/j.jphotobiol.2004.11.02310.1016/j.jphotobiol.2004.11.023 ↗
10. 10.1016/0195-6701(95)90070-510.1016/0195-6701(95)90070-5 ↗
11. 10.1016/j.biomaterials.2008.09.02010.1016/j.biomaterials.2008.09.020 ↗
12. 10.1039/b820561b10.1039/b820561b ↗
13. 10.1039/c2jm31987j10.1039/c2jm31987j ↗
14. 10.1039/c3ra42629g10.1039/c3ra42629g ↗
15. 10.1038/nrc107110.1038/nrc1071 ↗
16. 10.1146/annurev.bioeng.7.060804.10043210.1146/annurev.bioeng.7.060804.100432 ↗
17. 10.1562/2005-05-11-ir-52510.1562/2005-05-11-ir-525 ↗
18. 10.1002/anie.20080016910.1002/anie.200800169 ↗
19. 10.1016/j.bbrc.2006.07.16010.1016/j.bbrc.2006.07.160 ↗
20. 10.1038/nmeth.124810.1038/nmeth.1248 ↗
21. 10.1021/acs.chemrev.6b0029010.1021/acs.chemrev.6b00290 ↗
22. 10.2217/nnm.09.910.2217/nnm.09.9 ↗
23. 10.1038/nmat454210.1038/nmat4542 ↗
24. 10.1002/smll.20050010510.1002/smll.200500105 ↗
25. 10.1088/0957-4484/19/44/44510210.1088/0957-4484/19/44/445102 ↗
26. 10.1016/j.biomaterials.2014.02.01410.1016/j.biomaterials.2014.02.014 ↗
27. 10.1039/c1nr10131e10.1039/c1nr10131e ↗
28. 10.1038/ncomms559610.1038/ncomms5596 ↗
29. 10.1007/s40843-016-0115-010.1007/s40843-016-0115-0 ↗
30. 10.1002/smll.20130145910.1002/smll.201301459 ↗
31. 10.1039/b926535j10.1039/b926535j ↗
32. 10.1021/jp301103f10.1021/jp301103f ↗
33. 10.1021/nl034733410.1021/nl0347334 ↗
34. 10.1021/la060093j10.1021/la060093j ↗
35. 10.1016/j.biomaterials.2016.07.01410.1016/j.biomaterials.2016.07.014 ↗
36. 10.1016/j.nano.2018.07.00910.1016/j.nano.2018.07.009 ↗
37. Pikett, N. D. S.; Mushtaq, I. Preparation of Nanoparticle Materials. U.S. Patent 7,588,828 B2, Sep 15, 2009.
38. 10.1039/c5tb00971e10.1039/c5tb00971e ↗
39. 10.1111/exd.1225710.1111/exd.12257 ↗
40. 10.1016/j.jaad.2009.03.02910.1016/j.jaad.2009.03.029 ↗
41. 10.1016/j.det.2010.08.00910.1016/j.det.2010.08.009 ↗
42. 10.1016/s0896-8446(02)00026-810.1016/s0896-8446(02)00026-8 ↗
43. 10.1016/s1386-1425(02)00044-610.1016/s1386-1425(02)00044-6 ↗
44. 10.1063/1.43517710.1063/1.435177 ↗
45. 10.1016/0009-2614(80)85283-310.1016/0009-2614(80)85283-3 ↗
46. 10.1021/jp981185n10.1021/jp981185n ↗
47. Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery and Development of New Antibiotics; World Health Organization (WHO), 2017.
48. 10.1101/cshperspect.a00041410.1101/cshperspect.a000414 ↗
49. 10.1039/c5ra08788k10.1039/c5ra08788k ↗
50. 10.1039/c7sc00592j10.1039/c7sc00592j ↗
51. 10.1021/ja804308510.1021/ja8043085 ↗
52. Lakowicz J. R. · 200610.1007/978-0-387-46312-4 ↗
53. 10.1039/b813919a10.1039/b813919a ↗
54. 10.1021/jp030140610.1021/jp0301406 ↗
55. 10.1016/1010-6030(95)04303-910.1016/1010-6030(95)04303-9 ↗
56. 10.1016/0009-2614(85)87281-x10.1016/0009-2614(85)87281-x ↗
57. 10.1111/j.1751-1097.1998.tb09443.x10.1111/j.1751-1097.1998.tb09443.x ↗
58. 10.1021/jp911801m10.1021/jp911801m ↗
59. 10.1039/c6cp02529c10.1039/c6cp02529c ↗
60. 10.1002/smll.20130145910.1002/smll.201301459 ↗
61. 10.1039/c5ra09045h10.1039/c5ra09045h ↗
62. 10.1515/pac-2014-050210.1515/pac-2014-0502 ↗
63. 10.1021/j100641a00810.1021/j100641a008 ↗
64. 10.1021/jp046781y10.1021/jp046781y ↗
65. 10.1016/s0009-2797(86)80095-310.1016/s0009-2797(86)80095-3 ↗
66. Fischer V. · Photobioch. Photobiop. · 1984 · 7 · 111
67. 10.1016/j.freeradbiomed.2011.05.02310.1016/j.freeradbiomed.2011.05.023 ↗
68. 10.1016/j.dyepig.2003.10.01210.1016/j.dyepig.2003.10.012 ↗
69. 10.1021/jacs.8b0501410.1021/jacs.8b05014 ↗